Sanofi (SNYNF)
97.95
-2.05
(-2.05%)
USD |
OTCM |
Dec 03, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 118.96B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 4.40% |
| Valuation | |
| PE Ratio | 12.23 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 2.819 |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 4.350 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 34.79% |
Profile
| Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France. |
| URL | http://www.sanofi.com |
| Investor Relations URL | https://www.sanofi.com/en/investors |
| HQ State/Province | Ile-de-France |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jan. 29, 2026 |
| Last Earnings Release | Oct. 24, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 13, 2025 |
Ratings
Profile
| Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France. |
| URL | http://www.sanofi.com |
| Investor Relations URL | https://www.sanofi.com/en/investors |
| HQ State/Province | Ile-de-France |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jan. 29, 2026 |
| Last Earnings Release | Oct. 24, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | May. 13, 2025 |